Microfluidic Affinity Profiling reveals a Broad Range of Target Affinities for Anti-SARS-CoV-2 Antibodies in Plasma of COVID-19 Survivors
View ORCID ProfileMatthias M. Schneider, Marc Emmenegger, Catherine K. Xu, Itzel Condado Morales, Georg Meisl, Priscilla Turelli, Chryssa Zografou, Manuela R. Zimmermann, Beat M. Frey, Sebastian Fiedler, Viola Denninger, Raphaël P. B. Jacquat, Lidia Madrigal, Alison Ilsley, Vasilis Kosmoliaptsis, Heike Fiegler, Didier Trono, View ORCID ProfileTuomas P. J. Knowles, View ORCID ProfileAdriano Aguzzi
doi: https://doi.org/10.1101/2020.09.20.20196907
Matthias M. Schneider
1Centre for Misfolding Diseases, Yusuf Hamied Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, UK
Marc Emmenegger
2Institute of Neuropathology, University of Zurich, 8091 Zurich, Switzerland
Catherine K. Xu
1Centre for Misfolding Diseases, Yusuf Hamied Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, UK
Itzel Condado Morales
2Institute of Neuropathology, University of Zurich, 8091 Zurich, Switzerland
Georg Meisl
1Centre for Misfolding Diseases, Yusuf Hamied Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, UK
Priscilla Turelli
3School of Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland
Chryssa Zografou
2Institute of Neuropathology, University of Zurich, 8091 Zurich, Switzerland
Manuela R. Zimmermann
1Centre for Misfolding Diseases, Yusuf Hamied Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, UK
Beat M. Frey
4Regional Blood Transfusion Service Zurich, Swiss Red Cross, 8952 Schlieren, Switzerland
Sebastian Fiedler
5Fluidic Analytics, Unit A, The Paddocks Business Centre, Cherry Hinton Rd, Cambridge CB1 8DH, UK
Viola Denninger
5Fluidic Analytics, Unit A, The Paddocks Business Centre, Cherry Hinton Rd, Cambridge CB1 8DH, UK
Raphaël P. B. Jacquat
1Centre for Misfolding Diseases, Yusuf Hamied Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, UK
Lidia Madrigal
2Institute of Neuropathology, University of Zurich, 8091 Zurich, Switzerland
Alison Ilsley
5Fluidic Analytics, Unit A, The Paddocks Business Centre, Cherry Hinton Rd, Cambridge CB1 8DH, UK
Vasilis Kosmoliaptsis
6Department of Surgery, Addenbrooke’s Hospital, University of Cambridge, Hills Road, Cambridge CB2 0QQ, UK
7NIHR Blood and Transplant Research Unit in Organ Donation and Transplantation, University of Cambridge, Hills Road, Cambridge CB2 0QQ, UK
Heike Fiegler
5Fluidic Analytics, Unit A, The Paddocks Business Centre, Cherry Hinton Rd, Cambridge CB1 8DH, UK
Didier Trono
3School of Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland
Tuomas P. J. Knowles
1Centre for Misfolding Diseases, Yusuf Hamied Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, UK
8Cavendish Laboratory, Department of Physics, University of Cambridge, JJ Thomson Ave, Cambridge CB3 0HE, UK
Adriano Aguzzi
2Institute of Neuropathology, University of Zurich, 8091 Zurich, Switzerland
Posted September 08, 2021.
Microfluidic Affinity Profiling reveals a Broad Range of Target Affinities for Anti-SARS-CoV-2 Antibodies in Plasma of COVID-19 Survivors
Matthias M. Schneider, Marc Emmenegger, Catherine K. Xu, Itzel Condado Morales, Georg Meisl, Priscilla Turelli, Chryssa Zografou, Manuela R. Zimmermann, Beat M. Frey, Sebastian Fiedler, Viola Denninger, Raphaël P. B. Jacquat, Lidia Madrigal, Alison Ilsley, Vasilis Kosmoliaptsis, Heike Fiegler, Didier Trono, Tuomas P. J. Knowles, Adriano Aguzzi
medRxiv 2020.09.20.20196907; doi: https://doi.org/10.1101/2020.09.20.20196907
Microfluidic Affinity Profiling reveals a Broad Range of Target Affinities for Anti-SARS-CoV-2 Antibodies in Plasma of COVID-19 Survivors
Matthias M. Schneider, Marc Emmenegger, Catherine K. Xu, Itzel Condado Morales, Georg Meisl, Priscilla Turelli, Chryssa Zografou, Manuela R. Zimmermann, Beat M. Frey, Sebastian Fiedler, Viola Denninger, Raphaël P. B. Jacquat, Lidia Madrigal, Alison Ilsley, Vasilis Kosmoliaptsis, Heike Fiegler, Didier Trono, Tuomas P. J. Knowles, Adriano Aguzzi
medRxiv 2020.09.20.20196907; doi: https://doi.org/10.1101/2020.09.20.20196907
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (708)
- Anesthesia (201)
- Cardiovascular Medicine (2942)
- Dermatology (249)
- Emergency Medicine (439)
- Epidemiology (12743)
- Forensic Medicine (12)
- Gastroenterology (828)
- Genetic and Genomic Medicine (4583)
- Geriatric Medicine (417)
- Health Economics (729)
- Health Informatics (2916)
- Health Policy (1069)
- Hematology (389)
- HIV/AIDS (924)
- Medical Education (425)
- Medical Ethics (115)
- Nephrology (469)
- Neurology (4353)
- Nursing (236)
- Nutrition (639)
- Oncology (2268)
- Ophthalmology (646)
- Orthopedics (258)
- Otolaryngology (325)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (501)
- Pediatrics (1196)
- Primary Care Research (496)
- Public and Global Health (6937)
- Radiology and Imaging (1527)
- Respiratory Medicine (915)
- Rheumatology (437)
- Sports Medicine (385)
- Surgery (488)
- Toxicology (60)
- Transplantation (212)
- Urology (180)